chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Syncope
Clinical narrative: Patient received Shingles vaccine first. She stated that she felt ok after and then after administration of flu shot she fainted
Age: 12.0
Sex: M
Vaccine: DTAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt mother stated no adverse reactions
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Myalgia, Pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: Vaccine was injected improperly high up in my upper left  arm near the joint.  I had very bad pain starting about 2 hrs after injection and could barely extend my arm. This lasted for about 48 hrs . Pain has  gotten somewhat better but I still have decreased range of motion with my left arm and increased muscle pain  if I try to extend my arm to  90 degrees or more . This has continued  now for approx 3 weeks .
Age: 12.0
Sex: U
Vaccine: DTAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: spoke w/ pt mom over phone, she stated he had no adverse reactions
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Deafness, Magnetic resonance imaging, Tinnitus
Clinical narrative: Tinnitus and hearing loss necessitating hearing test, ENT appointment and MRI
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Loss of personal independence in daily activities, Tic, Tourette's disorder
Clinical narrative: Patient has been diagnosed with Tourette's Syndrome and she will likely always have it to some degree.  That being said, she has not had any severe tics in the last 3 years.  After receiving the vaccine on 11/8, she began experiencing severe symptoms (tics) on 11/9.  These tics left her unable to function due to the nature of the tics (constant vocal tics that cause her to be unable to breath until a series has been completed).  The first set lasted for about 3 hours.  On the 10th, she had more manageable symptoms.  On the 11th, they began again and by the evening of the 11th, she was unable to function once again.  The "attacks" lasted for about 18 hours at all times other than when she was able to sleep.  Not only were these the first attacks she's had in over 3 years, they have been by far the most severe tics she has had in her life.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Enlarged lymph node, sought treatment/examination at Dr. and was referred to Dr.. Had slight increase in lymph node size after Spikevax vaccine on October 1, 2024 but was told to watch and visit Dr. in 6 months
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Patient has erythema, pain, swelling, tenderness and induration at injection site.  Patient said she can't barely move her arm the day after the vaccine but now she is feeling better.
Age: 60.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Chest X-ray normal, Cough, Eye infection, Metabolic function test normal, Nasopharyngitis
Clinical narrative: Day following injection, had sore throat for a week. Then cough started. Went to doctor after 1.5 weeks and received antibiotics for sinus infection, chest cold and eye infection.
Age: 60.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Oropharyngeal pain, SARS-CoV-2 test negative, Sinusitis
Clinical narrative: Day following injection, had sore throat for a week. Then cough started. Went to doctor after 1.5 weeks and received antibiotics for sinus infection, chest cold and eye infection.
Age: 8.0
Sex: F
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: DTaP administered when Tdap was recommended.
Age: 64.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Patient was given a dose of Arexvy after already receiving one in November of 2023.
Age: 1.0
Sex: F
Vaccine: FLU3, HEPA, HIBV, PNC20
Symptoms: Dyspnoea, Erythema, Injection site erythema, Skin warm, Urticaria
Clinical narrative: Patient received the above 4 vaccines. Within about 5 minutes, she had urticaria covering both lower extremities. It did not seem to start on one leg and spread to the other but appeared on both legs simultaneously. She had no wheezing, shortness of breath or vomiting. She was observed for 30 minutes. Within about 10 minutes of the initial reaction, the erythema and warmth of the urticaria had diminished. She was given a dose of Zyrtec. She was reassessed about 4 hours later, and urticaria had resolved. She had no shortness of breath, wheezing or vomiting throughout this time. She did not receive epinephrine. She did have some mild erythema around injection site on her right thigh, but no wheal.
Age: 1.0
Sex: F
Vaccine: FLU3, HEPA, HIBV, PNC20
Symptoms: Vomiting, Wheezing
Clinical narrative: Patient received the above 4 vaccines. Within about 5 minutes, she had urticaria covering both lower extremities. It did not seem to start on one leg and spread to the other but appeared on both legs simultaneously. She had no wheezing, shortness of breath or vomiting. She was observed for 30 minutes. Within about 10 minutes of the initial reaction, the erythema and warmth of the urticaria had diminished. She was given a dose of Zyrtec. She was reassessed about 4 hours later, and urticaria had resolved. She had no shortness of breath, wheezing or vomiting throughout this time. She did not receive epinephrine. She did have some mild erythema around injection site on her right thigh, but no wheal.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Syncope
Clinical narrative: The patient fainted shortly after receiving the vaccine. Her husband was there and helped to revive her shortly after. She hit her head on a padded chair in the vaccination room when she fainted. She was able to leave the store without additional assistance shortly after regaining consciousness. She reported that this has happened to her before.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Product administered at inappropriate site
Clinical narrative: Area below injection site with erythema, swelling, and warmth. Injection site was given to mid arm by nurse, lower than recommended site.
Age: 28.0
Sex: F
Vaccine: RSV
Symptoms: Exposure during pregnancy, Injection site bruising, Injection site erythema, Injection site pruritus
Clinical narrative: Local itching, redness and bruising to injection site;  EDD:12/4/24
Age: 77.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Arthritis, Back pain, Nerve compression, X-ray
Clinical narrative: Inflamation in joints and back which resulted in severe pain.  Urgent care prescribed oral steroid, Gabapentin and Celebrex.  Pain subsided after two days, issue related the back (sciatic nerve impingement) improved in three to four days.
Age: 26.0
Sex: F
Vaccine: HEPA, HPV9, TDAP
Symptoms: Immediate post-injection reaction, Injection site bruising, Injection site nodule
Clinical narrative: When tetanus shot was given a "knot" immediately was visible at injection site, with mild bruising.
Age: 11.0
Sex: F
Vaccine: COVID19, FLU3, VARCEL
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: Incorrect date of birth given on record
Age: 6.0
Sex: F
Vaccine: MMRV
Symptoms: Product preparation error
Clinical narrative: MMR vaccine mixed with Sodium Chloride not the sterile water provided by Merck & Co and administered on 11/11/24. Contacted State Immunization program the next business day (state closed on 11/11/24) and was told that because it was not the provided sterile water it is considered an adverse event and the dose would have to be repeated.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Injection site pain, Loss of personal independence in daily activities, Mobility decreased, Musculoskeletal stiffness
Clinical narrative: Received flu shot at office on 10/10/24.   Injection given in left arm and did hurt more than is usually does whenI have gotten a flu shot in the past.  Pain has continued since I received shot and has been getting worse each day.  I have trouble staying asleep at night becuase of pain to my left should and arm.  When getting dressed my arm hurts and feels stiff.  I have reduced movement in my arm which make dressing harder.  Pain is worse in the morning, evening and during the night.  Saw provider when pain persisted 10/22/24 and Orthopedic Clinic 11/6/24.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Sleep disorder
Clinical narrative: Received flu shot at office on 10/10/24.   Injection given in left arm and did hurt more than is usually does whenI have gotten a flu shot in the past.  Pain has continued since I received shot and has been getting worse each day.  I have trouble staying asleep at night becuase of pain to my left should and arm.  When getting dressed my arm hurts and feels stiff.  I have reduced movement in my arm which make dressing harder.  Pain is worse in the morning, evening and during the night.  Saw provider when pain persisted 10/22/24 and Orthopedic Clinic 11/6/24.
Age: 41.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Angiogram, Atrial fibrillation, Blood test, Myocardial infarction, Ultrasound scan
Clinical narrative: Afib heart attack. In hospital for two days. Still on meds, being monitored and tested.
Age: 41.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: X-ray
Clinical narrative: Afib heart attack. In hospital for two days. Still on meds, being monitored and tested.
Age: 66.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: NO ADVERSE REACTION. VACCINE GIVEN WAS EXPIRED BY 1 MONTH
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Chest X-ray normal, Dyspnoea, Electrocardiogram normal, Headache
Clinical narrative: Sleepless, fever, headache, nausea, shortness of breath
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Pyrexia
Clinical narrative: Sleepless, fever, headache, nausea, shortness of breath
Age: 65.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Acute sinusitis, Bronchitis, Chills, Hyperhidrosis, Otitis media
Clinical narrative: Fever sweating chills beginning 24 hours after vaccination. Subsequently developed acute sinusitis, otitis media, and acute bronchitis and lasted for six weeks.
Age: 65.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Pyrexia
Clinical narrative: Fever sweating chills beginning 24 hours after vaccination. Subsequently developed acute sinusitis, otitis media, and acute bronchitis and lasted for six weeks.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Paralysis
Clinical narrative: PT STATED HE RECIEVED FLU SHOT ON 10/1 AND EXPERIENCED PARALYSIS BY 10/29
Age: 48.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Headache, Imaging procedure, Laboratory test, Ocular discomfort, Photopsia
Clinical narrative: Posterior vitreous detachment in left eye first noted on 10/26/24; signs included flashes of light, floaters, blurred vision, headache, eye pressure; symptoms persist daily up to and including today, 11/12/24
Age: 48.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vision blurred, Vitreous detachment, Vitreous floaters
Clinical narrative: Posterior vitreous detachment in left eye first noted on 10/26/24; signs included flashes of light, floaters, blurred vision, headache, eye pressure; symptoms persist daily up to and including today, 11/12/24
Age: 55.0
Sex: M
Vaccine: FLU3, PNC20
Symptoms: Cellulitis orbital, Computerised tomogram head abnormal, Exophthalmos, Myositis, Periorbital cellulitis
Clinical narrative: Acute orbital cellulitis showing radiological evidence suggestive of pre and post-septal cellulitis with myositis, left eye protrusion, facial peeling
Age: 55.0
Sex: M
Vaccine: FLU3, PNC20
Symptoms: Skin exfoliation
Clinical narrative: Acute orbital cellulitis showing radiological evidence suggestive of pre and post-septal cellulitis with myositis, left eye protrusion, facial peeling
Age: 41.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Asthenia, Chills, Fatigue, Headache, Injection site bruising
Clinical narrative: Fever, Chills, headaches, weakness and body aches, injection side pain swelling and bruising, Nausea and fatigue. Started around 3:00am on 11/12/2024. Currently having symptoms.
Age: 41.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Injection site swelling, Nausea, Pain, Pyrexia
Clinical narrative: Fever, Chills, headaches, weakness and body aches, injection side pain swelling and bruising, Nausea and fatigue. Started around 3:00am on 11/12/2024. Currently having symptoms.
Age: 69.0
Sex: F
Vaccine: PNC20
Symptoms: Hypersensitivity, Injection site pruritus, Pruritus
Clinical narrative: Patient came into the pharmacy on 11/12/24 to report an allergic reaction to Prevnar 20. Per patient, the next day after receiving Prevnar 20 on 11/4/24, her whole body started itching.  She also reported to her family doctor, who confirmed that she was allergic to the vaccine. It's been 8 days after the vaccine, and the injection site is still itchy.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Patient describes a localized reaction. Developed soreness later in the day after vaccination and then a day and half later, he had bruising and a bump and swelling at injection site. He states that the bump has been getting smaller but is still present.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite
Clinical narrative: no appetite
Age: 1.0
Sex: F
Vaccine: COVID19, FLU3, HEPA, MMR, PNC20, VARCEL, VARCEL
Symptoms: No adverse event
Clinical narrative: no symptoms at this time
Age: 81.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness in swelling in both arms, much worse in the right arm, which received the Moderna Spikevax vaccine than the left, where received the HD Fluzone immunization. The entire upper right arm was red, hot and swollen. The left arm had a palm-sized area or redness and swelling on the upper arm.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Brain fog, Malaise, Menstrual disorder, Pyrexia
Clinical narrative: patient stated fever, feeling unwell/foggy, started her period after not having it for 15+ years, on the IUD.
Age: 0.5
Sex: M
Vaccine: HIBV
Symptoms: Product preparation issue
Clinical narrative: diluent was injected without being mixed with powder
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Received FLUAD for 65+ instead of FLUARIX.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: pt came in to Dr and stated to me that she has severe pain in her left arm where her shot was given. it was very difficult for her to elevate her arm up due to the pain
Age: 51.0
Sex: F
Vaccine: RSV
Symptoms: Body temperature increased, Head discomfort, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: BODY TEMPERATURE INCREASING WARM. NOSE AND LIPS ARE GETTING NUMB FEELING. HEAD FELT HEAVY.
Age: 16.0
Sex: M
Vaccine: HPV9
Symptoms: Fall, Syncope
Clinical narrative: Patient experienced a syncopal event 2 minutes after injection. Normal pulse and respirations, throughout. He awoke about 1 minute after the fall, as we returned him to his chair we conducted multiple neurologic exams that were within normal limits. He remained alert and oriented x4. Initial BP 90/66 but improved 110/70. We contacted family later in the afternoon noting that he has continued to remain well
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: Heplisav-B was administered while patient is pregnant with 17 weeks. No adverse reaction or baby's issue at the moment.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Pt reported to pharmacy 11/12/24. She stated she developed redness and itching on her arm. The site of the redness is below the injection site. She stated this started a few days after the injection on 11/8/24. She stated today the redness was resolving and it was getting better. I advised her to seek medical care should it worsen or develop symptoms of an infection.
Age: 10.0
Sex: F
Vaccine: FLUN3
Symptoms: Contraindication to vaccination, No adverse event
Clinical narrative: Patient's parent reported patient uses inhaler as needed, and it was determined that the patient should receive an injectable flu vaccine (IIV). However, the patient received FluMist.  This occurred at a school-located mass vaccination clinic.  Parent notified and verbalized understanding of s/sx to look for.  No reported adverse reaction occurred.
Age: 30.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Injected limb mobility decreased, Injection site pain, Pain, Periarthritis, Product administered at inappropriate site
Clinical narrative: Client states at the time of administration, injections were very painful due to being very high up and near the shoulder. Pain has not stopped since administration and continues to be "general ache" with increased pain upon movement. Client states she cannot lift her arm more than 2 inches without significant pain and has been diagnosed with frozen shoulder. She has sought medical evaluation and will need to be evaluated by an orthopedic surgeon. Client called to discuss incident, reporter called her back and obtained details on 11/12/2024.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Sciatica
Clinical narrative: Sciatica
Age: 60.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Computerised tomogram kidney abnormal, Culture urine negative, Nephrolithiasis, Urine analysis abnormal, White blood cell count increased
Clinical narrative: Kidney stone. Passed 10 days after symptoms began.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: Patient had previously received a flu vaccination at another facility prior to receiving one today at our facility.  Unsure of the exact date of first vaccination.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Seizure
Clinical narrative: seizure occurred 8 hours after injection, hospitalization for 5 days
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Neuralgia, Sensory loss
Clinical narrative: Patient had muscle spasms in back and along left arm with nerve pain and loss sensation in left arm. He went to the ER 11/11/24 at hospital and was prescribed gabapentin 300mg three times daily.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Paraesthesia
Clinical narrative: no issues for first week (no pain or soreness). after about 1 week began to feel sore and pain in arm anytime pt tries to move it. Rubbing or touching has no issues, only when moving does it hurt. Sometime experiences tingling in fingers which is new as well. pain/tingling  has yet to improve.
Age: 70.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pruritus, Sleep disorder
Clinical narrative: Morning after vaccines were administered, patient stated she her arm from her deltoid to about 3 inches below her elbow was bright red, painful to the touch, and swollen. Said it was too painful to sleep on her left side until the night of 11/11. Did not report until today at 11/12. Her arm was still red, but no longer bright red, and slightly swollen from the middle portion of her bicep to approximately 3 inches below her elbow. Only outer aspect of arm affected; no swelling or redness reported around her tricep or inner arm. Patient stated her arm is currently very itchy but is pleased that it seems to be improving. She said she's never had any adverse reactions to any vaccine before but is now hesitant to receive her second Shingrix dose.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Mon/day, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024 , before the updated guidelines could be implemented.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Back pain, Pain
Clinical narrative: Severe left shoulder, left upper back pain with movement
Age: 32.0
Sex: M
Vaccine: COVID19, HEP
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Father presented wanting mengingcoccal vaccination and received men b vaccine. Mother states that they needed booster.
Age: 0.33
Sex: M
Vaccine: FLU3
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: FLU VACCINE GIVEN AT INAPPROPRIATE AGE, 6 MONTHS MINIMUM AGE, PATIENT ONLY 4 MONTHS OLD
Age: 11.0
Sex: M
Vaccine: COVID19, TDAP
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 52.0
Sex: F
Vaccine: COVID19, HEP, MMR
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: I don?t know dose .
Age: 36.0
Sex: M
Vaccine: COVID19, HEP, MMR, TDAP
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 60.0
Sex: M
Vaccine: COVID19, FLU3, VARZOS
Symptoms: Injection site erythema
Clinical narrative: Patient received one vaccine on the left and two vaccines on the right. Patient was not sure of what vaccines he got on which arm. Patient stated that the only side effect that he has gotten was this big red spot that was forming on his left arm. He stated that it kept growing bigger and bigger each day, but stated that it did not have any reactions. He stated that it wasn't warm to touch or itchy. He said he has taken Benadryl, but has stated that there was no effect. Patient came to pharmacy on 11/12/24 to see which vaccine it was. Pharmacy was unsure what vaccine it was, but patient stated that the spot is growing smaller and smaller. Recommended to use an ice pack if needed and wait a few days for it to disappear.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024.As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 36.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024.As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 30.0
Sex: M
Vaccine: COVID19, HEP, TDAP
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 4.0
Sex: M
Vaccine: COVID19, DTAPIPV, HEPA, MMRV
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 59.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Periarthritis
Clinical narrative: Frozen shoulder symptoms haa returned. They had been almost entirely absent for 3 months.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Local redness, swelling, heat, pain for 3 days. Resolved on it's own.
Age: 30.0
Sex: M
Vaccine: COVID19, TDAP, VARCEL
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 26.0
Sex: F
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/22/2024, before the updated guidelines could be implemented.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/25/2024, before the updated guidelines could be implemented.
Age: 42.0
Sex: F
Vaccine: COVID19, HEP, MMR, TD
Symptoms: Discontinued product administered
Clinical narrative: On Friday, August 23, 2024, the Local Health Department was notified via email by the state at 4:01 p.m. about the updated 2024-2025 mRNA COVID-19 vaccines, with instructions dispersed by the FDA on August 22, 2024, advising providers to remove any remaining 2023-2024 COVID-19 vaccine stock from their inventory. The local Health Department read and distributed this information upon returning to work on Monday, August 26, 2024. As a result, a vaccine from the 2023-2024 stock was administered to this client on 08/23/2024, before the updated guidelines could be implemented.
Age: 79.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Condition aggravated, Seizure
Clinical narrative: Patient's wife reported on 11/12/24 he had episode of seizure the next day following the vaccine (11/05/2024).  He was seen by his neurologist and emergency doctor. He is better now per his wife/
Age: 71.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Chills, Lethargy, Pyrexia
Clinical narrative: Patient said she had a fever, chills and felt lethargic for about 24 hours.
Age: 1.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Rash papular
Clinical narrative: Erythematous papular rash that started near the LEFT EAR with large margin of erythema. Spread to be scattered papules of the truck, extremties, and face.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Patient said his entire arm was numb.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain lower, Abdominal tenderness, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin normal
Clinical narrative: 10/17/24, 4:41pm- Pt's daughter, called clinic to say her mom got a flu shot the day before and today not feeling well with BP 80/51.  Call transferred to RN but patient wasn't with her mom at the time of call so requested she have her mom call clinic right away.  4:46pm- After not hearing right back RN called patient and reached her on the phone. Copied from Triage call by RN with patient 4:46- Pt speaking clearly and in complete sentences but states she has a hard time catching her breath "at times."  She states after clinic appt yesterday (and rec'd flu shot) she felt fine for a couple hours but then got the chills and fever 100.1 and states "my legs wouldn't work right" and was very dizzy.  She states her oxygen level was 80-84%.  Asked her if she's still feeling that way now and states yes.  Asked if anyone is with her and states her husband is there taking a nap.  Told her I'm going to call EMS for her- placed her call on hold.  Merged call w/ EMS and gave s/s info that pt reported- pt not able to give EMS her address- this RN read off physical address on demographics form and pt concurred that's what it is.  EMS operator states she dispatched Fire Dept now and then hung up.  This RN stayed on line w/ pt waiting for EMS.  Pt checked her BP again while waiting and states it's 92/59.  Encouraged her to sit with feet elevated to help with that.  Pt states last time she had a flu shot was 8 years ago and states she had these same type symptoms and "they took me to the hospital and said I had meningitis."  Asked her if she told staff yesterday that she'd had problems w/ previous flu shot- she didn't answer that question and chatting about other things.  (Checked flu shot consent record and no issues were reported by pt of past problems.)  While on phone husband and neighbor now with her.  Pt still speaking easily and clearly without obvious SOB heard over phone.  Pt's neighbor provided his phone # if needed.  (RN hung up while husband and neighbor waiting for medics to arrive.)  Clinic telephone note by RN 10/17, 10:29am: Reviewed portal and see pt was taken by ambulance to [Hospital] yesterday after our triage call- notes scanned to electronic health record.  Tel call to pt now- she states she's still a little achy but dizziness and low BP issues have resolved- feeling better overall.  Offered f/u appt time on Monday but states she won't have a ride until T, W or Th.  Scheduled f/u w/ Dr. for Wed, 10/23 at 11am.  Instructed that if she feels worse at all to call clinic again.  She acknowledged that plan.  (ER diagnoses were reaction from flu vaccine reaction, UTI and dehydration.)  RN added Influenza Vaccine to allergy list in patient's electronic health record on 10/17/24.  Patient returned to clinic 10/23/24 for ER follow-up visit.  She was directed to complete her course of treatment for UTI (from ER) and said she was feeling better with home BP checks back to normal.